Women's Special Issue Series: Pharmacy and Pharmacists

A special issue of Pharmacy (ISSN 2226-4787).

Deadline for manuscript submissions: 31 October 2025 | Viewed by 1638

Special Issue Editors


E-Mail Website
Guest Editor
School of Medical Sciences and Dentistry, Charles Sturt University, Orange Campus, Orange, NSW 2800, Australia
Interests: disciplinary pharmacy practice; pharmacy education; telehealth; technology in health; digital health; professional identity development; assessment and workplace learning
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Faculty of Pharmacy & Pharmaceutical Sciences, University of Alberta, 3-229 Edmonton Clinic Health Academy, Edmonton, AB T6G 1C9, Canada
Interests: geriatrics; geriatric syndromes; falls; attitudes toward older adults; deprescribing; medication appropriateness
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Institute of Pharmacy, Faculty of Medicine, University of Tartu, 1 Nooruse Sreeet, 50411 Tartu, Estonia
Interests: pharmaceutical development; pharmacy; drug information; pharmacy education; clinical pharmacy; drug safety; hospital pharmacy; therapeutic drug monitoring; herbal medicine; patient safety
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

We are grateful to all authors, reviewers, academic editors, and readers for their support of the first edition of our Special Issue entitled “Women’s Special Issue Series: Pharmacy”. You can access these articles for free via the following link: Women’s Special Issue Series: Pharmacy.

To celebrate and highlight the achievements of women in pharmacy academic research, this 2nd edition “Women’s Special Issue Series: Pharmacy and Pharmacists” will continuously present related work from female scientists in pharmacy education and practice. We also hope that this Special Issue will further encourage and promote the scientific contributions of female researchers in this field.

We cordially invite researchers to submit their work on topics across all areas of Pharmacy Education and Practice. Review articles, original research papers, and communications are all welcome.

Articles where women are lead or senior authors are encouraged. We welcome submissions from all authors, irrespective of gender.

Dr. Maree Donna Simpson
Prof. Dr. Cheryl A. Sadowski
Dr. Daisy Volmer
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • pharmacy
  • pharmacists
  • pharmacy services
  • pharmacy practice
  • pharmacy education
  • pharmacy workforce
  • pharmaceutical care
  • medication use/management

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Related Special Issue

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

13 pages, 227 KiB  
Article
Latvian Healthcare Professionals’ Self-Reported Knowledge, Attitudes, and Behaviors Related to Pregnancy Prevention Program Materials for Valproate-Containing Medicines
by Milana Špoģe, Mirdza Kursīte and Elita Poplavska
Pharmacy 2024, 12(6), 182; https://doi.org/10.3390/pharmacy12060182 - 4 Dec 2024
Viewed by 444
Abstract
Background: Valproates are recognized for their significant teratogenic risks, which can lead to physical defects and developmental disorders when used during pregnancy. To mitigate these risks, the Pregnancy Prevention Program (PPP) was developed by European regulators for patients and healthcare professionals (HCPs). Despite [...] Read more.
Background: Valproates are recognized for their significant teratogenic risks, which can lead to physical defects and developmental disorders when used during pregnancy. To mitigate these risks, the Pregnancy Prevention Program (PPP) was developed by European regulators for patients and healthcare professionals (HCPs). Despite the crucial nature of this program, the implementation of the PPP does not appear to be fully effective. This situation highlights the need for a deeper understanding of HCPs’ knowledge, attitudes, and behaviors regarding the PPP. Methods: A cross-sectional study using anonymous electronic questionnaires was conducted. The questionnaires were developed by a board of experts from eight different EU countries and were distributed among prescribers (general practitioners (GPs), neurologists, and psychiatrists) and pharmacists. Descriptive statistics were used to analyze the obtained data on participants’ knowledge, attitudes, and behaviors regarding the prescribing and dispensing of valproate-containing medicines to women of reproductive age, as well as the impact of PPP materials on their work. Results: The study results indicate that while HCPs in Latvia are generally aware of valproate teratogenic risks, significant gaps remain in the implementation of the PPP. A considerable number of both prescribers and pharmacists expressed the belief that they are not responsible for educating patients about the PPP, attributing this responsibility to other specialists. Furthermore, barriers such as a lack of time and accessible materials were identified. Conclusions: The roles and responsibilities of HCPs should be clearly defined to improve adherence to the PPP. Further research is needed to assess prescription and dispensing strategies, as well as HCPs’ attitudes toward the PPP. Additionally, re-evaluating and enhancing the accessibility of PPP materials is essential in effective risk management and better patient care. Full article
(This article belongs to the Special Issue Women's Special Issue Series: Pharmacy and Pharmacists)
13 pages, 1080 KiB  
Article
Drug Shortages in Albania: Pharmacists’ Experiences and Perspectives
by Delina Xhafaj, Sonila Vito and Alban Xhafaj
Pharmacy 2024, 12(6), 166; https://doi.org/10.3390/pharmacy12060166 - 7 Nov 2024
Viewed by 675
Abstract
Drug shortages are a significant global issue, particularly affecting healthcare systems in resource-limited countries such as Albania. Pharmacists play a critical role in managing these shortages, yet little is known about their experiences and perspectives. This study aims to explore pharmacists’ views on [...] Read more.
Drug shortages are a significant global issue, particularly affecting healthcare systems in resource-limited countries such as Albania. Pharmacists play a critical role in managing these shortages, yet little is known about their experiences and perspectives. This study aims to explore pharmacists’ views on the current drug shortages in Albania, identifying the most affected drug classes, and suggesting potential strategies for mitigating these shortages. A cross-sectional survey was conducted with 93 pharmacists across Albania between December 2023 and May 2024. Data were collected using an online questionnaire that addressed the types of drugs experiencing shortages, the causes of these shortages, and pharmacists’ coping strategies. Cardiovascular and central nervous system medications were reported as the most frequently affected, with supply chain disruptions, regulatory hurdles, and low domestic production cited as key contributors. The findings suggest an urgent need for national policy reforms focusing on improving supply chain resilience and boosting the local pharmaceutical production. The pharmacists proposed mitigation strategies, including stricter regulatory oversight, improved communication channels, and increased local production to reduce dependence on imports. These recommendations underscore the study’s contribution to understanding how tailored, pharmacist-informed strategies could strengthen Albania’s healthcare system. Full article
(This article belongs to the Special Issue Women's Special Issue Series: Pharmacy and Pharmacists)
Show Figures

Figure 1

Back to TopTop